| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +400K | 32% | $45.97 | +$18.4M |
| Sells | 8 | -851K | 68% | $48.38 | -$41.2M |
| Net | -7 | -451K | -36% | -$22.8M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Graham G. Walmsley | Director | $58.8M | +$18.4M | +45.5% | Oct 8, 2025 |
| Andrew Cheng | President and CEO, Director | $23.5M | -$15.5M | -39.7% | Nov 20, 2025 |
| Jonathan Young | Chief Operating Officer | $14M | -$5.18M | -27% | Nov 24, 2025 |
| Seth Loring Harrison | Director | $13.2M | Jun 3, 2025 | ||
| Timothy Rolph | Chief Scientific Officer | $5.95M | -$9.31M | -61% | Nov 25, 2025 |
| Skorpios Trust | Former 10% owner | $2.01M | Dec 1, 2022 | ||
| Patrick Lamy | Senior VP, Commercial Strategy | $1.71M | -$1.44M | -45.8% | Jul 1, 2025 |
| Catriona Yale | Chief Development Officer | $1.58M | -$9.15M | -85.3% | Nov 4, 2025 |
| William Richard White | Chief Financial Officer | $1.39M | -$386K | -21.7% | Sep 11, 2025 |
| Scott A. Gangloff | Chief Technology Officer | $517K | -$46.5K | -8.25% | Aug 15, 2025 |
| Jane Henderson | Director | $446K | -$142K | -24.2% | Aug 12, 2025 |
| Tomas J. Heyman | Director | $422K | Jun 3, 2025 | ||
| Yuan Xu | Director | $422K | Jun 3, 2025 | ||
| Mark T. Iwicki | Director | $422K | Jun 3, 2025 | ||
| Chou Judy | Director | $422K | Jun 3, 2025 | ||
| Kevin Bitterman | Director | Jun 1, 2021 | |||
| ATP Life Science Ventures, L.P. | 10%+ Owner | Jun 28, 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|